IL6 and autoimmune myocarditis: Low-dose MTX has been shown to reduce levels of TNF-α and interleukin-6 (IL-6) and increase the level of IL-10 in the plasma of rats with cardiac myosin-induced autoimmune myocarditis, as well as increase left-ventricular ejection fraction and fractional shortening [123].